SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001079973-24-000041
Filing Date
2024-01-08
Accepted
2024-01-08 16:01:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G mercer_13g.htm SC 13G 40033
  Complete submission text file 0001079973-24-000041.txt   41745
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Subject) CIK: 0001643918 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89366 | Film No.: 24520001
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 107 GRAND STREET 7TH FLOOR NEW YORK NY 10013
Business Address 107 GRAND STREET 7TH FLOOR NEW YORK NY 10013 202-778-9100
Mercer Street Global Opportunity Fund, LLC (Filed by) CIK: 0001816725 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G